ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,184.24
0.09%
Dow Jones
41,794.60
-0.61%
Gold vs US Dollar
2,736.825
-0.08%
Brent Oil
75.225
1.55%
Bitcoin
67,464.12
-1.86%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
04/11/202421:02PR Newswire (US)Abry Partners and BHMS Announce Sale of Innovisk to Ryan SpecialtyNYSE:RYANRyan Specialty Holdings Inc
04/11/202421:02PR Newswire (US)ITC Holdings Corp. Appoints Two New Members to Board of Directors
04/11/202421:02PR Newswire (US)'Tis the Season to Decorate with Festive Grinch Décor from Gemmy
04/11/202421:02PR Newswire (US)Parking Concepts Inc. Appoints Victor Alistar as Vice President for Northern California Region
04/11/202421:01PR Newswire (US)Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo™NASDAQ:SNDXSyndax Pharmaceuticals Inc
04/11/202421:01PR Newswire (US)Flotek Announces Increased 2024 Guidance, Improved Revenue, and Continued Profit Growth in Connection with Third Quarter 2024 ResultsNYSE:FTKFlotek Industries Inc
04/11/202421:01PR Newswire (US)GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:GRALGRAIL Inc
04/11/202421:01PR Newswire (US)Coveo Reports Second Quarter Fiscal 2025 Financial ResultsTSX:CVOCoveo Solutions Inc
04/11/202421:01PR Newswire (US)Heidrick & Struggles Reports Third Quarter 2024 ResultsNASDAQ:HSIIHeidrick and Struggles International Inc
04/11/202421:01PR Newswire (US)Sanmina Reports Fourth Quarter and Fiscal 2024 Financial ResultsNASDAQ:SANMSanmina Corporation
04/11/202421:01PR Newswire (US)Semler Scientific® Reports Third Quarter 2024 Financial Results and Additional Bitcoin PurchasesNASDAQ:SMLRSemier Scientific Inc
04/11/202421:01PR Newswire (US)Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo™NASDAQ:RPRXRoyalty Pharma PLC
04/11/202421:01UK RegulatoryWillScot to Participate in Baird Global Industrial ConferenceLSE:0A1NWillscot Corp
04/11/202421:00PR Newswire (US)Wine Spectator announces its lineup of producers for the 2025 edition of "OperaWine: Finest Italian Wines" during wine2wine Business Forum 2024
04/11/202421:00PR Newswire (US)MySmile Oral Care: The Best in Teeth Whitening, Flossing, and Brushing for an Unbeatable Price
04/11/202421:00PR Newswire (US)Students Tour Allegion's Technical Glass Products Operations in Snoqualmie for 2024 MFG Day Field Trip
04/11/202421:00PR Newswire (US)NOVATAE RISK GROUP LAUNCHES EXCLUSIVE MISCELLANEOUS PROFESSIONAL LIABILITY PROGRAM
04/11/202421:00PR Newswire (US)Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and InnovationNASDAQ:INBXInhibrx Biosciences Inc
04/11/202421:00PR Newswire (US)WOW! REPORTS THIRD QUARTER 2024 RESULTSNYSE:WOWWideOpenWest Inc
04/11/202421:00PR Newswire (US)S&P Global to Present at J.P. Morgan 2024 Ultimate Services Investor Conference on November 14, 2024NYSE:SPGIS&P Global Inc
04/11/202421:00PR Newswire (US)Summit Midstream Corporation Schedules Third Quarter 2024 Earnings CallNYSE:SMCSummit Midstream Corporation
04/11/202420:50PR Newswire (US)Greenberg Traurig Named Finalist in 5 Categories for The Oath Middle East Legal Awards 2024
04/11/202420:50PR Newswire (US)AVET PHARMA ANNOUNCES A SETTLEMENT WITH THE STATE ATTORNEY GENERAL PLAINTIFFS IN GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION
04/11/202420:49PR Newswire (US)Military Makeover with Montel® Launches Season 41 Honoring the LaVallee Family in West Palm Beach, FL
04/11/202420:48PR Newswire (US)Notice of Proposed Derivative Settlement: Lyft, Inc.
04/11/202420:45PR Newswire (US)FirstService Residential Opens State-of-the-Art South Region Headquarters
04/11/202420:44PR Newswire (US)Castilla y León Wines Announces Successful East Coast Roadshow and Upcoming West Coast Tour in 2024
04/11/202420:41PR Newswire (US)Lupus Research Alliance Announces Lupus Research Highlights at ACR Convergence 2024
04/11/202420:40PR Newswire (US)The Grounds Guys Launches 20th Annual WeCARE Week: A Legacy of Giving Back
04/11/202420:40PR Newswire (US)VoIP Services Market to Expand by USD 21.59 Billion from 2024-2028, Driven by Cost Efficiency and AI-Powered Market Evolution Insights - Technavio

Your Recent History

LSE
SYME
Supply@me Capital
LSE
PANR
Pantheon Resources
LSE
BP.
Bp
LSE
SBTX
Skinbiotherapeutics
LSE
TERN
Tern
LSE
AFC
Afc Energy
LSE
TXP
Touchstone Exploration
LSE
AAZ
Anglo Asian Mining
LSE
GOLD
LSE
POS
Plexus
LSE
BIRD
Blackbird
LSE
UOG
United Oil & Gas
LSE
SAVE
Savannah Energy
LSE
LLOY
Lloyds Banking
LSE
VAST
Vast Resources
LSE
THG
Thg
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved